US Stock MarketDetailed Quotes

VRAX Virax Biolabs

Watchlist
  • 0.6636
  • +0.0056+0.85%
Close Apr 24 16:00 ET
1.57MMarket Cap-189P/E (TTM)

About Virax Biolabs Company

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

Company Profile

SymbolVRAX
Company NameVirax Biolabs
Listing DateJul 21, 2022
Issue Price5.00
Founded2013
CEOMr. James Foster
MarketNASDAQ
Employees11
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
Address20 North Audley Street
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW1K 6LX
Phone44-20-7788-7414

Company Executives

  • Name
  • Position
  • Salary
  • James Foster
  • Chief Executive Officer and Chairman of the Board
  • 1.63M
  • Jason Davis
  • Chief Financial Officer
  • 923.50K
  • Dr. Tomasz George
  • Chief Scientific Officer
  • 451.25K
  • Mark Ternouth
  • Chief Technical Officer
  • 405.56K
  • Cameron Shaw
  • Director and Chief Operating Officer
  • 1.59M
  • Yair Erez
  • Independent Director
  • 96.10K
  • Nelson M. Haight
  • Independent Director
  • 42.18K
  • Evan Norton
  • Independent Director
  • 96.10K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg